Author(s): Taher AT, Viprakasit V, Musallam KM, Cappellini MD
Abstract Share this page
Abstract Despite receiving no or only occasional blood transfusions, patients with non-transfusion-dependent thalassemia (NTDT) have increased intestinal iron absorption and can accumulate iron to levels comparable with transfusion-dependent patients. This iron accumulation occurs more slowly in NTDT patients compared to transfusion-dependent thalassemia patients, and complications do not arise until later in life. It remains crucial for these patients' health to monitor and appropriately treat their iron burden. Based on recent data, including a randomized clinical trial on iron chelation in NTDT, a simple iron chelation treatment algorithm is presented to assist physicians with monitoring iron burden and initiating chelation therapy in this group of patients. Copyright © 2013 Wiley Periodicals, Inc.
This article was published in Am J Hematol
and referenced in Journal of Blood Disorders & Transfusion